Table 1 Reported RDT sensitivity and specificity data for included studies
From: Use of malaria RDTs in various health contexts across sub-Saharan Africa: a systematic review
Author | Year | Sensitivity (95% CI) | Specificity (95% CI) |
|---|---|---|---|
Formal Health Care Sector | |||
 Ashton | 2010 | 85.6% | 92.4–92.7% |
 Baiden | 2012 | 100% | 73.0% (67–78) |
 Chinkhumba | 2010 | 90–97% | 39–68% |
 de Oliveira | 2009 | 91.7 (80.8–100.0) | 96.7 (92.8–100.0) |
 Diarra | 2012 | 89.6% (88.1–90.9) | 81.1% (78.8–83.2) |
 Gerstla | 2010 | 99.4% (96.8–100.0) | 96.0% (91.9–98.4) |
 Gerstlb | 2010 | 98.8% (95.8–99.8) | 74.7% (67.6–81.0) |
 Guthmann | 2002 | 97% | 88% |
 Hopkinsa | 2007 | 85% | 99.8% |
 Hopkinsb | 2007 | 92% | 93% |
 McMorrow | 2008 | 64.8% | 87.8% |
 McMorrow | 2010 | 90.7% | 73.5% |
 Moonasar | 2009 | 85% | 96% |
 Morankar | 2011 | 93% | 99.4% |
 Msellem | 2009 | 94% | 88% |
 Mtove | 2011 | 97.5% (96.9–98.0) | 65.3% (63.8–66.9) |
 Nicastrip | 2009 | 69.2% | 100% |
 Osei-Kwakye | 2013 | 97.7% (95.8–99.0) | 58.1% (53.8–62.3) |
 Ouattara | 2011 | 97.2% | 95.4% |
 Shakely | 2013 | 78.6% (70.8–85.1) | 99.7% (99.5–99.9) |
 Shakelyp | 2013 | 76.5% (69.0–83.9) | 99.9% (99.7–100) |
 Shekalaghe | 2013 | 94.7% (89.8–97.3) | 95.6% (94.2–96.6) |
Retail Sector | |||
 Ansah | 2015 | 98–100% | 30–98% |
 Mbonye | 2015 | 91.7% | 63.1% |
Community Health Workers | |||
 Ishengomac | 2011 | 88.6% | 88.2% |
 Ishengomad | 2011 | 63.4% | 94.3% |
 Mubi | 2011 | 85.3% | 59.8% |
 Ndyomugyenyie | 2016 | 72.1% | 83.3% |
 Ndyomugyenyif | 2016 | 20.8% | 98.1% |
 Ratsimbasoae | 2012 | 90.2% (81.7–95.7) | 87.2% (78.3–93.4) |
 Ratsimbasoaf | 2012 | 93.7% (69.8–99.4) | 83.3% (35.9–99.6) |
 Tiono | 2013 | 97.9% (96.3–98.8) | 53.4% (49.1–57.7) |
 Willcox | 2009 | 82.9% (78.0–87.1) | 78.9% (63.9–89.7) |